Press Release | NeoGenomics Laboratories

December 11, 2018

NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder

December 10, 2018

NeoGenomics Completes Acquisition of Genoptix, Inc.

November 30, 2018

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

October 30, 2018

QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs

October 23, 2018

NeoGenomics Signs Definitive Agreement to Acquire Genoptix

October 1, 2018

NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018

September 24, 2018

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

September 12, 2018

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients